AstraZeneca CEO Urges Western Drugmakers to Move at 'Chinese Speed'
Jul 27, 2026
AstraZeneca CEO Pascal Soriot urges Western pharma to accelerate innovation against Chinese rivals, likening the challenge to the automotive industry's EV shift. Despite a recent trial failure, the company targets $80bn annual sales by 2030 while leveraging AI to enhance drug development speed.